PharmaAfter close
Astal Laboratories approves share capital increase and acquisition
after close1 source ↓written by the desknot a recommendation
- General Meeting
- 6 Nov 2025
- through an equity
- 100% stake in Sriven Pharmachem
Astal Laboratories Limited held an Extraordinary General Meeting on 6 Nov 2025, where it approved a share capital increase and the acquisition of 100% stake in Sriven Pharmachem through an equity share swap. This strategic move aims to enhance its market position and expand its product offerings. Traders should monitor the implications of these corporate actions on stock performance.
Not investment advice. For informational purposes only.